Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck KGaA

Showing 15 posts of 91 posts found.

Merck KGaA pushes biosimilars

February 12, 2014
Research and Development, Sales and Marketing Dr Reddy's, Merck KGaA, biosimilars, dr reddys, generics

Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …

News
matthias_zachert_merck

Merck KGaA head jumping ship to Lanxess

January 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck KGaA, lanxess, zachert

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …

Appointment
Erbitux image

Merck KGaA declines in Q2

August 7, 2013
Sales and Marketing Erbitux, Merck KGaA, Q2, Serono

Sales of cancer drug Erbitux dropped as Merck Serono’s revenues for the second quarter of 2013 dipped year-on-year, the firm …

News
Merck KgAA

Merck, Hedinger first suppliers certified under excipient scheme

August 1, 2013
Manufacturing and Production Merck, Merck KGaA

Merck KGaA’s EMD Millipore unit and fellow German firm Hedinger have become the first two excipient suppliers to be certified …

News

Merck KGaA/BMS China deal

March 22, 2013
Sales and Marketing BMS, Merck KGaA, diabetes

Merck KGaA and Bristol-Myers Squibb are to co-promote the German firm’s veteran diabetes drug Glucophage in different formations in China. …

News

Knee trial for Merck KGaA

March 19, 2013
Research and Development, Sales and Marketing Merck KGaA, knee, nordic

Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …

News

Merck KGaA pipeline hit

December 21, 2012
Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline

Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …

News
merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012
Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …

News

Merck KGaA confirms leadership team appointments

June 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMD Serono, Merck KGaA, Serono

The subsidiary of Merck KGaA named EMD Serono has announced several appointments to its leadership team. The appointments include: Allene …

Appointment
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012
Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …

News

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012
Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …

News

Merck KGaA swings axe over Serono operations

April 25, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …

News
Merck KGaA image

Merck KGaA manufacturing under scrutiny by FDA

March 27, 2012
Manufacturing and Production FDA, Merck KGaA, Rebif, Violations, manufacturing

The US Food and Drug Administration has asked Merck KGaA to undertake a ‘comprehensive and global assessment’ of its manufacturing …

News

Mini-labs to fight counterfeit drugs in Africa

March 2, 2012
Sales and Marketing Africa, Merck KGaA, Zambia, counterfeits

Merck KGaA is donating equipment which can detect counterfeit drugs, while also increasing its commitment to eradicating schistosomiasis in Africa. …

News
Rebif image

Rebif approved for early use in MS

January 26, 2012
Sales and Marketing MS, Merck KGaA, Merck Serono, Rebif

The European Commission has approved an indication for multiple sclerosis treatment Rebif that treats early signs of the condition.This EC …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023